Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia-Reference-Cited by-同舟云学术

Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia

Published:2020-07 Issue:2 Volume:76 Page:131-142
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Blom Dirk J.,Harada-Shiba Mariko,Rubba Paolo,Gaudet Daniel,Kastelein John J.P.,Charng Min-Ji,Pordy Robert,Donahue Stephen,Ali Shazia,Dong Yuping,Khilla Nagwa,Banerjee Poulabi,Baccara-Dinet Marie,Rosenson Robert S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society;Cuchel;Eur Heart J,2014

2. Managing the challenging homozygous familial hypercholesterolemia patient: academic insights and practical approaches for a severe dyslipidemia, a National Lipid Association Masters Summit;Hovingh;J Clin Lipidol,2017

3. Familial hypercholesterolemia treatments: guidelines and new therapies;Raal;Atherosclerosis,2018

4. The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging therapies;Sniderman;J Am Coll Cardiol,2014

5. The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol;Seidah;Glob Cardiol Sci Pract,2017

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The therapeutic effect of PCSK9 inhibitors on dyslipidemia: one-year follow up;European Journal of Translational Myology;2024-09-13

2. Molecular diagnostics of familial hypercholesterolemia in Russia: yesterday, today and tomorrow;Medical academic journal;2024-09-11

3. PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention;Lipids in Health and Disease;2024-09-10

4. Established and Emerging Nucleic Acid Therapies for Familial Hypercholesterolemia;Circulation;2024-08-27

5. Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA);Nutrition, Metabolism and Cardiovascular Diseases;2024-08